(Wired) – The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

Lennard Lee, a UK National Health Service oncologist and medical director at the Ellison Institute of Technology in Oxford, calls himself just a “simple doctor,” but he’s anything but. During the pandemic, he led clinical efforts that showed it was still safe to give cancer patients chemotherapy, disproving fears that the coronavirus made this too risky, helping to maintain cancer treatment worldwide. He also delivered UK research that showed lateral flow testing was effective in identifying the most infectious Covid patients.

His most important project, however, is the one he’s currently leading as the national government advisor for mRNA cancer vaccines. (Read More)